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a b s t r a c t
The rejection of cyclophosphamide (CP) by nanofiltration (NF) and reverse osmosis (RO)
membranes from ultrapure (Milli-Q) water and membrane bioreactor (MBR) effluent was
investigated. Lyophilization–extraction and detection methods were first developed for CP
analysis in different water matrices. Experimental results showed that the RO membrane
provided excellent rejection (>90%) under all operating conditions. Conversely, efficiency
of CP rejection by NF membrane was poor: in the range of 20–40% from Milli-Q water and
around 60% from MBR effluent. Trans-membrane pressure, initial CP concentration and
ionic strength of the feed solution had almost no effect on CP retention by NF. On the other
hand, the water matrix proved to have a great influence: CP rejection rate by NF was clearly
enhanced when MBR effluent was used as the background solution. Membrane fouling and
interactions between the CP and water matrix appeared to contribute to the higher
rejection of CP.
1. Introduction
The occurrence of pharmaceuticals in wastewater effluent
(Lishman et al., 2006; Vieno et al., 2007), drinking water sour-
ces (Kasprzyk-Hordern et al., 2008; Lindqvist et al., 2005) and
even in some treated drinking waters (Kim et al., 2007; Loraine
and Pettigrove, 2006), although often detected at trace levels
(sub-ng/L), has raised substantial concern in public and
regulatory agencies. Compounds with a very potent mecha-
nism of action, such as cytostatic drugs, are of particular
environmental concern because of the high potential risk and
the possible chronic adverse effects. Cyclophosphamide (CP)
is one of the very commonly used alkylating cytostatic drugs,
involved in the chemotherapy of various forms of cancer, in
the treatment of autoimmune diseases and used as an
immunosuppressant after organ transplantations (Grisolia,
2002). In the body, it is converted to active alkylating metab-
olites (phosphoramide mustards) through cytochrome P450
enzyme systems, which cause DNA adducts (cross-links) and
prevent cell division. This mechanism of action also accounts
for its adverse effects on living organisms, such as the muta-
genic, carcinogenic, teratogenic, and embryotoxic effects
described in the literature (Anderson et al., 1995).
CP exhibits poor biodegradability in the traditional acti-
vated sludge process of wastewater treatment plant (WWTP).
For example, only 17% of CP was removed from the waste
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stream in a laboratory scale activated sludge plant after 39
days of a continuous dosing experiment (Steger-Hartmann
et al., 1997). Buerge et al. (2006) also reported no CP degrada-
tion in activated sludge incubation experiments within 24 h at
a concentration of 100 ng/L. The low adsorption potential on
activated sludge is also to be expected because of the low
octanol–water partition coefficient of CP (log Kow¼ 0.63).
Ternes et al. (2004) found there was almost no CP adsorption
on the primary activated sludge of WWTP.
The high resistance to biodegradation and low adsorption
ability of CP indicate that this drug will be extremely persis-
tent in aqueous environments. Meanwhile, taking into
account the fact that the excretion of the unchanged parent
molecule in patients is around 20–45% (Bagley et al., 1973), CP
could be present in the surface water and ground water via
hospital or WWTP effluent. For example, Zuccato et al. (2000)
found 2–10 ng/L CP in the river Lombardy near Milan, Italy.
Buerge et al. (2006) also detected 0.15–0.17 ng/L CP in the river
Limmat, Switzerland. These exposure concentrations are
several orders of magnitude lower than the concentrations at
which acute ecotoxicological effects have been reported in the
literature. However, limited knowledge is available on chronic
health effects related to the consumption of drinking water
containing trace amounts of pharmaceuticals or their
metabolites (Johnson et al., 2008). In addition, the cytostatic
drug removal efficiencies of conventional drinking water
treatment processes, which were not designed to control
these emerging micro-pollutants, are limited (Ternes et al.,
2002). Therefore, it is unanimously accepted that preventing
such molecules from entering the aquatic environment is
essential. A precautionary approach is also desirable once
these compounds emerge during wastewater reuse and
drinking water production.
Nanofiltration (NF) and reverse osmosis (RO) are increas-
ingly used for water treatment, because of their complete or
nearly complete removal of a wide range of organic micro-
pollutants (Van der Bruggen and Vandecasteele, 2003). Many
researchers have evaluated the ability of several commercially
available NF/RO membranes to trap various pharmaceuticals.
Most of these studies try to explain the different mechanisms
that play a role in compound removal by controlling the
operating conditions or by comparing removal levels for
various targetmolecules (Kiso et al., 2001; Nghiem et al., 2005).
But the individual contributions of the influencing factors to
membrane retention are not well identified. In addition,
a broad range of pharmaceutical activated compounds
(PhACs) were selected as target molecules for a study with NF/
RO membrane (Verliefde et al., 2007). However, to the best of
our knowledge, CP has never been included in the above
research. Furthermore, very few studies have focused on the
influence of natural water matrices on solute removal by
membranes and the conclusions are conflicting in some cases.
For example, Yoon et al. (2006) studied the removal of 52
endocrine disrupting compounds (EDCs) and PhACs by NF and
UF membranes and found a decrease in compound rejection
with an increase in natural organic matter (NOM) concentra-
tion. But Comerton et al. (2008) found that the rejection of 22
EDCs and PhACs by NF membrane was enhanced in the
presence of organic matter when a natural water matrix was
used. Nghiem andHawkes (2007) reported that organic fouling
could both improve and lessen the retention of PhACs by NF
membranes.
The objective of the present study was to investigate
whether NF and RO membranes could be used to effectively
remove CP from water at trace level, not only in the tertiary
treatment of rawwater but also as a post-treatment process of
membrane bioreactor (MBR) in wastewater treatment, which
exhibits insufficient elimination of CP and its metabolites as
shown in a previous study (Delgado et al., 2008). The main
influencing factors and removal mechanisms were also
examined. Experiments were carried out in a dead-end batch
filtration cell in order to limit the volume of solutions and
control the operating parameters. The first series of experi-
ments was performed with a single solution of CP molecule in
Milli-Q water in order to evaluate the CP removal efficiency of
NF and RO membranes. Then the main influencing factors,
such as trans-membrane pressure, ionic strength and CP feed
concentration, were also investigated. The second series of
experiments was performed with mixed solutions of CP
molecule in MBR effluent to study the influence of the water
matrix on CP retention and to evaluate whether MBR–NF and
MBR–RO combined systems could be used directly for CP
removal from a target hospital discharge.
Before the filtration experiments, it was necessary to
develop sensitive and specific analysis methods, which
allowed quantification of CP at trace level in different water
matrices.
2. Materials and methods
2.1. Experimental set-up and filtration protocol
All experiments were performed in a dead-end stirred filtra-
tion cell made of stainless steel (see Causserand et al., 2005).
The effective membrane area was 3.52 10ÿ3m2 and the total
effective volume was about 400 mL. Stirring speed was
maintained constant (200 rpm) in all tests. Trans-membrane
pressure was exactly regulated by pressurized air through an
electronic pressure transducer (in the range 5 10þ5–
25 10þ5 Pa). The filtrate flux J (mL/min) was measured by an
electronic balance via a computer with an accuracy of 0.1 g.
All experiments were performed at room temperature
(20 3 C).
Before its first use, the membrane was soaked in ultrapure
water (Milli-Q) for 24 h. Then Milli-Q water was filtered
through it at 20 10þ5 Pa for about 2 h until the flux had
stabilized. The pure water permeability of the newmembrane
was then determined. After the pre-compaction, the cell was
emptied and filled with 380 mL of feed solution. Then the cell
was pressurized and the filtration was conducted until 200 mL
of permeate had been collected. The first 100-mL permeate
sample (named 100 mL permeate) and the second one (named
200 mL permeate) were collected separately for CP extraction
and further analysis. Feed and retentate samples were also
collected at the beginning and end of experiments respec-
tively. After the filtration run, the cell was emptied and the
membrane was washed thoroughly with Milli-Q water. Its
pure water permeability was measured again in order to
determine the difference before and after the filtration.
The observed retention coefficient: Robs¼ (1ÿ Cp/Cr) 100%
was calculated from concentrations determined in the
permeate Cp and the retentate Cr. When Cp was directly
quantified through permeate sample analysis, Crwas deduced
frommass balance, according to the fact thatwill be explained
in Section 3.1 that CP loss (by adsorption or other phenomena)
is negligible during filtration run. After each run, the
membrane and the O-ring gasket were replaced by new ones
in order to avoid cross contamination between runs by
adsorption–desorption of the molecules.
2.2. Membranes
The NF membrane: Desal 5 DK (Osmonics) used in this study
was a three-layer thin-film polysulfone-based membrane
with a polyamide top layer (provided by themanufacturer). Its
pure water permeability: 5.8 L/m2/h/bar (our measurements)
is especially high compared with other NF membranes (Maz-
zoni and Bandini, 2006). According to the information
provided by the manufacturer, this membrane possesses
a molecular weight cut-off of 150–300 gmolÿ1, a surface
energy of 33.10þ5 J mÿ2, a mean pore radius of 0.47 nm and
a negatively charged surface in the pH range of 4.4–8.3.
The selected RO membrane was a YMAKSP3001 (Osmon-
ics). It is also a polyamidemembranewhich is commonly used
in pharmaceuticals removal. It exhibits 99% NaCl retention
(provided by the manufacturer) and its pure water perme-
ability is 4.0 L/m2/h/bar (our measurements).
2.3. Chemicals and characterization
Cyclophosphamide monohydrate (CAS Number: 6055-19-2)
was purchased from Fluka, France. All reagents (humic acid,
sodium chloride, phosphoric acid) were norm-pure grade and
obtained from Sigma–Aldrich, France. All solvents (methanol,
acetonitrile, dichloromethane, ammonium formate) were of
HPLC grade from Fluka, France. Ultrapure water was used for
the preparation of all aqueous solutions and also as the high
performance liquid chromatography (HPLC) mobile phase and
as the eluent in liquid chromatography tandem mass spec-
trometry (LC/MS/MS).
The main properties of CP are listed in Table 1. This
substance is hydrophilic, judging from the low octanol–water
partition coefficient (log Kow< 2). The pKa value is given as
a range because no exact value can be found in the literature.
CP mainly exists in the neutral form within the normal pH
range of water.
2.4. Water matrix selection and characterization
Ultrapure water and effluent from an MBR were selected for
this study. The ultrapure water was produced from distilled
water through the Milli-Q filtration system (Millipore). The pH
valuewas in the range of 5–6 andwas kept constant during the
experiments.
The MBR system incorporated ZeeWeed 500 ultrafiltration
membranes (GE Zenon, France) and produced approximately
6 L of permeate per day while operating at a mixed liquor
suspended solid concentrations between 10 and 15 g/L.
Hydraulic retention time (HRT) and sludge retention time
(SRT) of MBR are 48 h and 50 days, respectively. Two small-
scale membrane bioreactors were run in parallel. Both reac-
tors were fed with a real municipal wastewater in which CP
concentration is below detection limit. One reactor was
operated as a blank: CP was never added to it; while the other
was doped with CP molecule to investigate CP removal effi-
ciency by the MBR process. The CP concentration supplied to
this MBR was 5–10 mg/L in accordance with the actual
concentration often found in the discharge from the target
hospital (in southern France). Generally, CP removal efficiency
in the MBR varied from 0 to 75% depending on the operating
conditions. Thus the CP concentration in MBR effluent was
about 1.5–10 mg/L (Delgado et al., 2008).
In the present study, the effluent from the blank reactor
was collected and spiked with CP for the filtration experi-
ments to study the influence of water matrix on CP rejection
by controlling the initial CP concentration. The main param-
eters of MBR effluent are reported in Table 2.
In order to study the CP retention mechanisms of NF and
RO membranes, CP concentration in the filtration experi-
ments with ultrapure water was relatively high (10–600 mg/L)
with respect to the detection limits of the analytical method.
Low CP concentration (1–10 mg/L) was adopted in the filtration
experiments with MBR effluent in order to simulate real levels
of occurrence in raw wastewater and MBR effluent as
mentioned before.
2.5. Sample extraction and analytical methods
2.5.1. Extraction
All CP samples were concentrated by a lyophilization–
extraction procedure. Briefly, 200 mL isofosfamide (0.1 mg/mL)
was added to a 100 mL CP sample as an internal standard. The
100 mL sample was frozen in a 500 mL glass bottle (Quickfit,
England) in a liquid nitrogen bath in a rotation evaporator
Table 1 – Main physicochemical properties of CP molecule.
Molecular formula Molecular weight (g/mol) log Kow pKa Charge at pH¼ 6–7 Molecular structure
C7H15Cl2N2O2P 261.09 0.63 4.5–6.5 Neutral
(Phenomenex, France) for about 12 min. Then the frozen
sample bottle was connected with the lyophilizer (CARLO
ERBA, France) for one night under vacuum conditions. After
lyophilization, the sample powder obtained was transferred
into a 30 mL glass tube (Scientific, France). 10 mL dichloro-
methane was then put into the bottle and shaken manually
for 10 min to completely dissolve the remaining powder. This
operation was repeated twice with 5 mL dichloromethane
and all the dichloromethane fractions were brought together
in a 30 mL tube. The sample tube was shaken gently in
a shaking bed (Stuart, France) for 30 min to further dissolve
the CP in the dichloromethane. The sample was centrifuged
for 10 min at 2000 rd/min. The dichloromethane phase was
transferred into a 20 mL glass tube with a pipette and the
tube was placed in the evaporator (PIERCE 18780, France) for
complete drying under a gentle nitrogen stream. These
operations were repeated twice with 5 mL dichloromethane.
Finally:
- for HPLC–UV analysis: 1000 mLwater–acetonitrile (80/20; v/
v) was added to the tube after drying and completely
mixed in a rotator.
- for LC–MS–MS analysis: 100 mL or 1000 mL (depending on
CP concentration) methanol/ammonium formate buffer
(50/50) was added, pH 5.7.
CP recoveries in the various water matrices were mostly
greater than 75% and the overall variability of themethodwas
below 8%. The extracted samples were stored at ÿ80 C for
further analysis. CP analysis was conducted with HPLC or LC/
MS/MS according to the ultimate concentration and detection
limit.
2.5.2. HPLC–UV
The HPLC–UV method was used for CP analysis at high
concentration and in ultrapure water. The HPLC equipment
consisted of an Accela pump, coupled to an Accela PDA
detector and an Accela auto sampler. The separation was
completed on a C18 Gemini column (particle size 3 mm,
0.2 10 cm). A C18 Gemini guard column (Phenomenex) was
also used. The UV detector was set at the wavelength of
195 nm for CP quantification. Column temperature was
maintained at 20 C. The injection volume was 5 mL. The
mobile phase was acetonitrile/water (20/80, v/v) and phos-
phoric acid was added to the mobile phase to adjust the pH to
2.5. Elution was performed at a flow rate of 0.4 mL/min under
isocratic conditions. The retention time of CP was about
5.0 min and the total run time was 12 min. The calibration
curve was established by injecting five CP standard solutions,
ranging from 4 to 48 mg/L. The correlation coefficient of CP
calibration showed good linearity (R2¼ 0.9990). A typical
quantification limit for CP samples under these conditions is
approximately 2 mg/L.
HPLC–UV is a time-saving, easily-controlled and relatively
economical detection method. This method was initially
adopted because of the large number of samples. However, it
was not suitable for the CP samples in complexwatermatrices
because of interference from other components (especially
NOM). For this reason, it was necessary to develop another
method for CP quantification in complex water matrices (MBR
effluent).
2.5.3. LC–MS–MS
The LC–MS–MS method was applied for CP confirmation and
quantification at lower CP concentration and in a complex
water matrix. The injection volume was 20 mL. The mobile
phase consisted of a gradient of methanol–ammonium
formate buffer (CH5NO2 2 mM, pH 5.7) circulated at an iso-
cratic flow rate of 0.20 mL/min (see Table 3). The column used
was a C18 Nucle´osil (particle size 100 A˚–5 mm, 0.2 12.5 cm).
Column temperature was maintained at 30 C. A guard
column was also used: Frit SS Blk 0.5 mm, 0.094 0.065 0.250
(Cil Cluzeau Info Labo).
The MS was operated in positive electrospray ionization
(ESIþ) mode using multiple reaction monitoring (MRM). The
scan range wasm/z [70–290] in theMS/MSmode, at a scan rate
of 3 m scans and 200 ms. Under ESIþ conditions, an abundant
protonated molecule [MþH]þ at m/z 233 and the fragment
ions atm/z 239, resulting from loss of chlorine, were observed.
The cone voltage and collision energy for each transition were
programmed through the Excalibur acquisition software.
The detection limit of the method was 10 ng/mL.
3. Results and discussion
3.1. CP rejection by NF membrane
3.1.1. Influence of trans-membrane pressure on CP retention
According to the detection limit of the HPLC–UV method and
multiple CP concentration factors during the extraction
procedure, 100 mg/L was the minimum CP concentration
(100 mL sample volume) which was suitable for HPLC–UV
analysis after extraction (100-fold concentration). At the same
time, taking into account the expected removal efficiency of
the NF membrane, CP initial concentration in the feed solu-
tion was fixed at 400 mg/L in this experiment. The solvent was
ultrapure water at its natural pH of about 6.0. During the
filtration run (less than 1 h) this pH remained stable. Fig. 1
shows the influence of trans-membrane pressure on CP
retention by NF membrane.
Table 3 – Methanol–ammonium formate buffer gradient.
Time (min) Mobile phase
0 80% buffer/20% methanol
9 80% buffer/20% methanol
9.5 55% buffer/45% methanol
25 55% buffer/45% methanol
Table 2 – Main parameters of MBR effluent.
COD
(mg/L)
Conductivity
(mS/cm)
pH N–NH3
(mg/L)
Dissolved
oxygen (mg/L)
150–300 20–50 7.5–8.0 2–5 6–8
Note: COD – Chemical Oxygen Demand.
It can be seen from this figure that the rate of CP rejection
by NFmembrane was relatively low, ranging from 20% to 40%.
Considering the low log Kow coefficient (hydrophobic
compounds are characterized by log Kow> 2) and the neutral
form of the CP molecule in the pH condition of the experi-
ments, we could expect weak interactions between CP mole-
cules and the membrane surface, which is hydrophobic and
negatively charged (see Materials and Methods section).
Taking into account the CP molecular weight (261.09 g/mol)
and the molecular weight cut-off (MWCO) of NF membrane
(180–300 g/mol, provided by the manufacturer), the low
rejection rate of CP seems to be consistent with a solute
transfer model mainly governed by a typical steric hindrance
mechanism. A similar conclusion was drawn by Kiso et al.
(2001) who showed that, for hydrophilic solutes, steric
hindrance was the most important controlling factor for
molecule rejection. Other evidences about this mechanism
will be further analyzed later in this paper.
It was also found that CP concentration in the first 100 mL
of permeate was always lower than that in the second 100 mL
of permeate. Thus CP rejection rate decreased from almost
40% after the first 100 mL filtered to 20% after 200 mL of
permeate filtered. This behavior can be attributed to weak
adsorption of CP onto the membrane in spite of the hydro-
philic character of the compound. In order to confirm this
assumption, the total quantity of CP adsorbed onto the
membrane was calculated from the mass balance after each
filtration run. The calculated results under various trans-
membrane pressures are reported in Table 4.
Given the low difference (between 5% and 7%) in the mass
balance listed in Table 4, we cannot settle the question of the
contribution of experimental error and of adsorption in the
values reported. However, this low quantity of CP loss during
experiments clearly demonstrated that interactions between
CP and the membrane surface were weak. We then assume
that if weak adsorption is effective, it may increase the
apparent CP retention rate at the beginning of the filtration
experiment without affecting membrane permeability due to
the low quantity adsorbed (see Section 3.1.4, Fig. 5). Further
investigation involved in the precise adsorption evaluation is
recommended. In consequence, 200 mL of permeate has to be
filtered in order to obtain an accurate evaluation of CP reten-
tion by NF membrane.
However, for the same volume filtered, CP rejection rate
was almost the same whatever the trans-membrane pressure
investigated. Desal 5 DK membrane retention efficiency was
not sensitive to pressure changes and exhibited almost
constant rejection performance for CP in the pressure range
5.2 10þ5–20.2 10þ5 Pa.
3.1.2. Influence of CP feed concentration on CP retention
The concentrations of CP found in sewage and drinking water
sources are in the order of ng/L. Such concentrations are
difficult to maintain in experiments due to analytical diffi-
culties (detection limits). Consequently, a higher concentra-
tion was used for the experimental study. This raises the
question of whether the conclusions drawn in the higher
concentration range are consistent with those that would be
deduced using lower concentrations. In this context, it was
necessary to investigate the influence of CP feed concentra-
tion on CP retention. CP solutions were prepared in ultrapure
water and filtered at 20 10þ5 Pa.
The CP concentrations selected here lay in two different
ranges: one was from 200 to 600 mg/L, for which samples were
analyzed by the HPLC–UV method, and the other was 10 mg/L,
for which samples were analyzed by the HPLC–MS–MS
method. Therewere two reasons for the selection here. Firstly,
10 mg/L of CP was to be used in the later filtration experiments
with MBR effluent as explained before, so it was necessary to
study whether CP retention remained constant throughout
the concentration range used. Secondly, it was also indis-
pensable to investigate the consistency of the two different
analytical methods used in this study.
As shown in Fig. 2, no obvious effect of CP initial concen-
tration on Robs value was observed in the concentration range
used in this experiment. A similar conclusion was drawn
when pesticides were filtered through the NF membrane in
the concentration range of several mg/L (Van der Bruggen et al.,
1998). Thus, within the experimental error, it can be
Fig. 1 – Influence of trans-membrane pressure on CP
rejection by NF.
Table 4 – Quantity of CP adsorbed on NF membrane.
Trans-membrane
pressure
(10þ5 Pa)
CP mass in
the feed
solution (mg)
CP mass in
permeate and
retentate (mg)
Total
quantity
adsorbed (%)
Total
quantity
adsorbed (mg/m2)
5.2 98.3 92.0 6.4 1.79
10.2 96.5 91.0 5.7 1.56
15.2 105.8 100.1 5.4 1.62
20.2 92.85 86.6 6.7 1.78
concluded that CP concentration in the feed solution has no
influence on CP rejection by NF membrane. Furthermore, we
can confirm that there was a good consistency between the
HPLC–UV and HPLC–MS–MS analysis methods.
3.1.3. Influence of ionic strength on CP retention
Sodium chloride was used to adjust the ionic strength in the
feed solution (25–50 mM). CP feed concentration in this
experiment was fixed at 400 mg/L and trans-membrane pres-
sure was 20 10þ5 Pa. Fig. 3 shows the CP rejection rate at
different ionic strengths. We see in this figure that the Robs
value of CP was almost constant whatever the ionic strength
of the feed solution, particularly after 200 mL of permeate
filtered. From these results, it appears that the presence of salt
does not affect CP retention by NF membrane.
In previous studies, some researchers have observed that
the presence of salt can alter the solute rejection behavior
(Nghiem et al., 2006; Bandini and Vezzani, 2003). For charged
solute, the presence of salt decreases the solute rejection rate.
This is due to the shield of electrostatic potential generated by
membrane surface functional groups, leading to a decrease in
electrostatic repulsive effects. On the other hand, the ‘‘salting-
out’’ effect decreases the hydrated radius of the solute mole-
cule and thus reduces the ‘‘apparent size’’ of the molecules.
Both effects would be expected to influence solute rejection in
similar ways and cannot be separated easily. However, in our
experiments, CP mainly existed in neutral form in the feed
solution as mentioned before. In these conditions, salting-out
and electrostatic repulsive interactions had a negligible effect
on the uncharged CP, the presence of salt had almost no
influence on CP retention. This also demonstrated that the
size exclusion mechanism governed CP retention by NF
membrane, while the electrostatic repulsion mechanism
played no role.
3.1.4. Influence of water matrix on CP retention
MBR effluent was used as a background solution to investigate
the influence of the water matrix on CP retention and to
evaluate the potential of nanofiltration as a post-treatment
process of MBR. Experiments were performed at a trans-
membrane pressure of 20 10þ5 Pa.
As the results in Fig. 4 show, the water matrix clearly
influences CP rejection by NF membrane. When MBR effluent
was used as the background solution, the CP rejection rate
was much higher than that in ultrapure water. Furthermore,
there was no obvious decrease in CP retention with the
filtration volume (the two CP rejection rate values with MBR
effluent are within experimental error). The CP retention
enhancement was principally attributed to membrane fouling
by the components (mainly natural organic matter) present in
MBR effluent. A decrease of 21% in membrane water perme-
ability was measured after filtration with MBR effluent as
shown in Fig. 5. Both in-depth membrane fouling due to the
Fig. 2 – Influence of CP feed concentration on CP rejection
by NF.
Fig. 3 – Influence of ionic strength on CP rejection by NF.
Fig. 4 – Influence of water matrix on CP rejection (CP feed
concentration: 10 mg/L).
Fig. 5 – Membrane water flux determined on a new
membrane, on the membrane after filtration of CP in
ultrapure water (10 mg/L) and after filtration of the solution
of CP in MBR effluent (10 mg/L).
NOM retention and NOM adsorption onto the membrane
surfacemay have contributed to themembrane permeate flux
decrease.
Considering the physicochemical properties of CP and the
conclusions of Section 3.1.3, the modification of membrane
surface properties (hydrophobicity, charge) caused by NOM
may have little effect on CP retention. Hence, the pore
restriction mechanism caused by NOM may play the greatest
role in the increase of CP rejection. In addition, the binding of
CP to NOM due to hydrogen bonding, forming NOM–CP
complexes that are larger and have an increased negative
charge, could also play a role in the removal of CP. Similar
conclusions have been drawn in a previous work (Comerton
et al., 2008). This study examined the rejection of 22 EDCs and
PhACs from different water matrices by ‘loose’ and ‘tight’ NF
membranes, and also an RO membrane. Among the investi-
gated compounds, Sulfamethizole exhibits similar properties
to CP’s ones (Molecular weight is 270 g/mol, log Kow is 0.54) In
spite of the compound characteristics, molecule rejection
from the natural waters by NF membrane was greater than
that from the Milli-Q water. It was concluded that membrane
fouling and compound interactions with the water matrix
likely contributed to the higher rejection.
Summarizing the above conclusions, we can state that NF
is not efficient enough in terms of CP removal to be considered
as a tertiary treatment for raw water containing CP. However,
it can be adopted as a post-treatment unit after an MBR
system in wastewater treatment. For example, if CP concen-
tration in the influent of the MBR was 10 mg/L (maximum
concentration detected in wastewater from the target
hospital), the removal efficiencies of the MBR and NF
membrane in steady state conditions were evaluated at 75%
and 60% respectively, so the CP concentration in the permeate
of the MBR–NF system would be less than 1 mg/L. The total
removal efficiency of the combined system would be greater
than 90%. So anMBR–NF system is a promising process for the
treatment of real wastewater containing CP in future appli-
cations. Furthermore, it can be expected that NF would
remove CP in non-MBR permeate if the water contained
similar organic material to the MBR permeate. Further inves-
tigation involved in the CP rejection by NF membrane alone
from natural raw water and wastewater is recommended.
3.2. CP rejection by RO membrane
The CP rejection experiments using an RO membrane were
conducted at relatively low concentrations (1–10 mg/L) in order
to simulate the actual applications and the LC–MS–MSmethod
was used for sample analysis. Table 5 shows the CP rejection
by ROmembrane under different operating conditions. As can
be seen from this table, the RO membrane provided excellent
CP rejection (>90%). Furthermore, the CP rejection rate was
almost stable under all operating conditions. No obvious
difference was observed when the trans-membrane pressure,
CP feed concentration and water matrix were changed.
Considering the high efficiency in terms of CP retention
whatever the operating conditions, an RO system could be
considered as the low risk option for tertiary treatment of raw
water containing CP as well as for a post-treatment unit after
the MBR system in wastewater treatment. For the latter
application, an MBR–RO system is an ideal choice for hospital
wastewater treatment since it can be expected to totally
remove many pharmaceutical compounds, such as CP, that
are assumed to be present at quite high concentrations in this
type of wastewater.
However, considering the filtrate flux obtained in the same
operating conditions (CP concentration inMBReffluent: 10 mg/L,
trans-membrane pressure: 20 10þ5 Pa): 3.5 mL/min with NF
membrane and 1.2 mL/min with ROmembrane, we can expect
a higher energy cost in the case of MBR–RO. To obtain the same
water productivity with an MBR–NF system, the applied trans-
membrane pressure for the MBR–RO system would have to be
increased.
4. Conclusions
In this paper, a lyophilization–extraction procedure was first
established for CP enrichment of different water matrices.
Sensitive and specific analysis methods based on HPLC–UV
and LC–MS–MS were also developed, and allowed quantifica-
tion of CP down to sub-ng/L concentrations. The rejection of
CP by NF and RO membranes from Milli-Q water and MBR
effluent was then investigated with CP feed concentrations
ranging from 1 to 600 mg/L. The RO membrane provided
excellent rejection (>90%) from the water matrices examined
under all operating conditions. This suggests that a combined
MBR–RO system could provide efficient removal of CP.
Concerning the NF process, this study has shown that the
typical steric hindrance mechanism governed CP retention by
NF membrane. Moreover, the results obtained demonstrated
that the adsorption phenomenon between CP and membrane
surface was weak but non-negligible as it led to an over esti-
mation of the CP rejection rate at the beginning of the filtra-
tion experiment. In consequence, an accurate evaluation of CP
removal by NFmembrane was achieved after filtering 200 mL.
Table 5 – CP rejection by RO membrane.
Trans-membrane
pressure (10þ5 Pa)
Water matrix CP feed
concentration (ng/L)
Concentration in
100 mL permeate (ng/L)
Concentration in
200 mL permeate (ng/L)
Robs1
(%)
Robs2
(%)
20.0 Ultrapure water 6338 218 364 96.57 94.26
20.0 Ultrapure water 4370 210 320 94.94 92.79
20.0 MBR effluent 1513 121 47 92.01 96.87
10.0 Ultrapure water 1252 61 42 93.70 96.62
10.0 MBR effluent 1382 103 43 92.53 96.67
Note: Robs1 is the CP rejection rate in the first 100 mL permeate; Robs2, the CP rejection rate in the second 100 mL permeate.
Rejection was poor from Milli-Q water: 20% in steady state
conditions. Trans-membrane pressure, CP initial concentra-
tion and ionic strength of the feed solution had almost no
influence on CP retention. On the other hand, the water
matrix greatly influenced the CP rejection behavior by NF. The
CP rejection rate was significantly enhanced when MBR
effluent was used as the background solution. Both
membrane fouling and interactions between CP and water
matrix may have contributed to the higher CP retention.
From this point of view, both MBR–NF and MBR–RO
combined systems can be considered as promising processes
for the treatment of real wastewater containing CP in future
applications.
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